These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 15542286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA, Pereira AC, Mota Gde F, Krieger JE, Mansur AJ.
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
    Pop D, Zdrenghea D, Procociuc LM, Popal A.
    Rom J Intern Med; 2007 Apr; 45(4):349-54. PubMed ID: 18767410
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 11. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT.
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Sep; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P, Majkowska L, Kaliszczak R, Safranow K, Adler G, Goracy I.
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [Abstract] [Full Text] [Related]

  • 19. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H, Li LM, Cao WH, Liu MZ, Sun NL, Lü J, Hu YH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [Abstract] [Full Text] [Related]

  • 20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.